Aurone derivatives as promising antibacterial agents against resistant Gram-positive pathogens.


Journal

European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510

Informations de publication

Date de publication:
01 Mar 2019
Historique:
received: 16 10 2018
revised: 07 01 2019
accepted: 10 01 2019
pubmed: 22 1 2019
medline: 22 3 2019
entrez: 22 1 2019
Statut: ppublish

Résumé

A set of variously substituted aurones was synthesized and evaluated against Methicillin-Resistant S. aureus (MRSA) and P. aeruginosa. Several analogues were found active against MRSA, but no effect was recorded against P. aeruginosa. Compounds 27, 30 and 33 showed low cytotoxicity, and were tested against a full range of bacterial (Gram-positive and Gram-negative) and fungal species, including resistant strains. These aurones displayed a selective inhibition of Gram-positive bacteria with excellent Therapeutic Index values, while showing no significant action on several Gram-negative strains, H. pylori and V. alginolyticus being the only susceptible strains among the Gram-negative bacteria tested. A permeabilization assay showed that the antibacterial activity of at least some of the aurones could be linked to alterations of the bacterial membrane. Overall, this study endorses the use of the aurone scaffold for the development of new potent and selective antibacterial agents.

Identifiants

pubmed: 30665143
pii: S0223-5234(19)30032-7
doi: 10.1016/j.ejmech.2019.01.022
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Benzofurans 0
aurone 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-141

Informations de copyright

Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Auteurs

Hamza Olleik (H)

Aix Marseille Univ., CNRS, Centrale Marseille, iSm2, Marseille, France.

Samir Yahiaoui (S)

Univ. Grenoble Alpes, CNRS, DPM UMR 5063, F-38041, Grenoble, France.

Brayan Roulier (B)

Univ. Grenoble Alpes, CNRS, DPM UMR 5063, F-38041, Grenoble, France.

Elise Courvoisier-Dezord (E)

Aix Marseille Univ., CNRS, Centrale Marseille, iSm2, Marseille, France.

Josette Perrier (J)

Aix Marseille Univ., CNRS, Centrale Marseille, iSm2, Marseille, France.

Basile Pérès (B)

Univ. Grenoble Alpes, CNRS, DPM UMR 5063, F-38041, Grenoble, France.

Akram Hijazi (A)

Lebanese University, Doctoral School of Science and Technology, PRASE, Beirut, Lebanon.

Elias Baydoun (E)

American University of Beirut, Department of Biology, Beirut, 1107 2020, Lebanon.

Josette Raymond (J)

Université Paris 5, Hôpital Cochin, Service de bactériologie, France.

Ahcène Boumendjel (A)

Univ. Grenoble Alpes, CNRS, DPM UMR 5063, F-38041, Grenoble, France.

Marc Maresca (M)

Aix Marseille Univ., CNRS, Centrale Marseille, iSm2, Marseille, France. Electronic address: m.maresca@univ-amu.fr.

Romain Haudecoeur (R)

Univ. Grenoble Alpes, CNRS, DPM UMR 5063, F-38041, Grenoble, France. Electronic address: Romain.Haudecoeur@univ-grenoble-alpes.fr.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation
Humans China Cerebral Hemorrhage Patient Care Bundles Length of Stay

Classifications MeSH